A detailed history of Coppell Advisory Solutions LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 1,124 shares of NVCR stock, worth $34,810. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,124
Previous 910 23.52%
Holding current value
$34,810
Previous $15.6 Million 12.56%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.61 - $23.34 $3,340 - $4,994
214 Added 23.52%
1,124 $17.5 Million
Q2 2024

Aug 15, 2024

BUY
$11.83 - $24.05 $10,765 - $21,885
910 New
910 $15.6 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.25B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.